A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases

<div>ROC curve and calibration plot of a new nomogram in validation cohort. (a) ROC curve of the model illustrated an AUC of 0.773 (95% CI: 0.681-0.865), which revealed a good concordance and a reliable ability to estimate the status of non-SLN metastasis in Chinese patients. (b) Calibration plot of a new nomogram.</div>

Disease Markers

fig6

Figure 6

Figure 6: A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases 

Figure 6 | A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases 